Am J Transplant, Volume 19, Suppl 3 Archives - Page 87 of 214 - ATC Abstracts

2019 American Transplant Congress
Perceptions and Attitude of Transplant Clinicians towards Antimicrobial Resistance and Stewardship in Transplant Recipients: A Survey of the American Society of Transplantation
M. So¹, J. Hand², M. Richmond¹, A. Morris³, S. Husain¹
¹University Health Network, Toronto, ON, Canada, ²Ochsner Medical Center, New Orleans, LA, ³Sinai Health System, Toronto, ON, Canada
*Purpose: The perceptions and attitude of transplant clinicians towards antimicrobial stewardship (AMS) is unclear. We conducted a survey to better understand their attitude and perceptions…
2019 American Transplant Congress
Normothermic Machine Perfusion of Human Kidneys without an Oxygen Carrier
D. Detelich, C. Eymard, M. Aburawi, C. Carroll, K. Uygun, H. Yeh, J. F. Markmann
Massachusetts General Hospital, Boston, MA
*Purpose: Normothermic machine perfusion (NMP) is a promising strategy for pre-transplant reconditioning and viability assessment of marginal renal grafts. All current clinical kidney NMP protocols…
2019 American Transplant Congress
Predicting Risk of Cytomegalovirus with Viral-Antigen-Specific CD154+ T-cells after Liver or Intestine Transplantation
C. Ashokkumar, K. Soltys, M. Green, G. Mazariegos, G. Bond, K. Jones, A. Rzempoluch, M. Zaccagnini, P. Sethi, B. W. Higgs, R. Sindhi
Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA
*Purpose: Cytomegalovirus (CMV)-specific T-cells express IFNγ, measure cell-mediated immunity to CMV and can guide the timing and duration of antiviral therapy. CMV-specific T-cells also co-express…
2019 American Transplant Congress
Urinary Extracellular Vesicles-Related Protein Biomarkers for the Non-Invasive Monitoring of Rejection in Kidney Transplanted Patients
L. Carreras-Planella¹, I. Bancu², D. Cucchiari³, L. Cañas², J. Juega², M. Franquesa¹, M. Perez-Mir², I. Revuelta³, F. Diekman⁴, R. Lauzurica², F. Borràs¹
¹REMAR-IVECAT Group, Institut Germans Trias i Pujol, Badalona, Spain, ²Nephrology- Renal Transplant Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ³Dept. Nefrologia i Trasplantament Renal, Institut Clínicde Nefrologia i Urologia (ICNU), Hospital Clinic, Barcelona, Spain, ⁴Dept. Nefrologia i Trasplantament Renal, Institut Clínicde Nefrologia i Urologia (ICNU), Hospital Clinic, Badalona, Spain
*Purpose: Chronic kidney rejection is currently the main cause of graft losses. Blood and urine analyses to monitor kidney transplanted patients are not specific, and…
2019 American Transplant Congress
Comparison between Urine and Blood NGAL for Early Prediction of Delayed Graft Function in Adult Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
Y. Li, Y. Li, L. Yan, H. Wang, X. Wu, J. Tang, L. Wang, Y. Shi
Department of Laboratory Medicine, West China Hospital, Chengdu, China
*Purpose: Neutrophil gelatinase-assoicated lipocalin (NGAL) appears to be a promising proximal tubular injury biomarker for early prediction of delayed graft function (DGF) in kidney transplant…
2019 American Transplant Congress
Evaluation of Liver Function and Biomarkers Predicts Tumor Progression in Treatment-Naïve Hepatocellular Carinoma Patients
K. Nunez, T. Sandow, S. Robertson, P. Thevenot, A. Cohen
Ochsner Health System, New Orleans, LA
*Purpose: Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer-related deaths in the world with recurrence rates at 40%. Locoregional therapy (LRT) is standard…
2019 American Transplant Congress
Unfair Waiting Time Calculation? Impact of Accumulated Wait Time Restart with a Decrease in Status from 1A to 1B or 2 on Mortality of Heart Transplant Candidates
S. Yu, M. Kosztowski, M. Waldram, D. L. Segev, A. B. Massie
Department of Surgery, Johns Hopkins, Baltimore, MD
*Purpose: Between two heart transplant (HT) candidates listed at the same status, the candidate with longer accumulated wait time receives higher waitlist priority; under current…
2019 American Transplant Congress
The Use Of First-year Intravascular Ultrasound In The Tacrolimus Era In Heart Transplantation
S. Dimbil¹, M. Kittleson¹, J. Patel¹, D. Geft¹, R. Cheng¹, R. Levine¹, T. Sato¹, L. Czer¹, R. Zabner², P. Zakowski², J. A. Kobashigawa¹, B. Azarbal¹
¹Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, ²Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Cytomegalovirus (CMV) has been documented as a risk factor for the development of cardiac allograft vasculopathy (CAV) after heart transplantation (HTx). It has not…
2019 American Transplant Congress
No Plan is a Bad Plan! Results of the American Society of Transplantation (AST) Living Donor Community of Practice Mortality Workgroup Survey on Disaster Planning Following a Living Donor Death
M. L. Henderson¹, S. E. Van Pilsum Rasmussen¹, M. M. Waldram¹, K. L. Lentine², D. A. Mandelbrot³, R. L. Hays³, D. G. Maluf⁴, M. Cooper⁵
¹Johns Hopkins, Baltimore, MD, ²Saint Louis University, St Louis, MO, ³University of Wisconsin, Madison, WI, ⁴University of Tennessee, Memphis, TN, ⁵Georgetown University, Washington, DC
*Purpose: The risk of perioperative mortality following living kidney and liver donation, although extremely low, must not be considered a ‘never event’. While the risks…
2019 American Transplant Congress
The Association of Kidney Transplant Center Volume with 3-Year Outcomes
E. M. Sonnenberg¹, J. B. Cohen², J. Y. Hsu³, V. S. Potluri², M. H. Levine¹, P. L. Abt¹, P. P. Reese²
¹Surgery, University of Pennsylvania, Philadelphia, PA, ²Renal Division, University of Pennsylvania, Philadelphia, PA, ³Biostatistics, University of Pennsylvania, Philadelphia, PA
*Purpose: To assess if a center volume-outcome relationship exists for contemporary kidney transplantation, specifically in increased-risk scenarios including: diabetic recipients, elderly recipients (age>65) or recipients…